![Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy | Science Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy | Science](https://www.science.org/cms/10.1126/science.aaf8399/asset/3e5349b9-a055-4160-a507-0792f488718d/assets/graphic/355_aaf8399_fa.jpeg)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy | Science
![Frontiers | The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA Frontiers | The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA](https://www.frontiersin.org/files/Articles/433509/fonc-09-00952-HTML/image_m/fonc-09-00952-g001.jpg)
Frontiers | The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
![Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study - eBioMedicine Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study - eBioMedicine](https://www.thelancet.com/cms/asset/10b243cd-5e42-4ff8-bef6-243e4c7db638/gr1.jpg)
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study - eBioMedicine
![Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2251-z/MediaObjects/12885_2016_2251_Fig1_HTML.gif)
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text
![DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load | Nature Communications DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-12159-9/MediaObjects/41467_2019_12159_Fig1_HTML.png)
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load | Nature Communications
![IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors](https://pub.mdpi-res.com/ijms/ijms-20-05999/article_deploy/html/images/ijms-20-05999-g001.png?1576130163)
IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
![Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis - ScienceDirect Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804919307579-gr1.jpg)
Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis - ScienceDirect
![Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies – PLOS Currents Evidence on Genomic Tests Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies – PLOS Currents Evidence on Genomic Tests](https://currents.plos.org/genomictests/files/2014/04/PLoS-EGT-NGS_authors-revisions_April-29-2014_Figure-1.png)
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies – PLOS Currents Evidence on Genomic Tests
![Relation of the tumor focality to mutation status and age of diagnosis.... | Download Scientific Diagram Relation of the tumor focality to mutation status and age of diagnosis.... | Download Scientific Diagram](https://www.researchgate.net/publication/364029168/figure/fig2/AS:11431281087251396@1664525796133/Relation-of-the-tumor-focality-to-mutation-status-and-age-of-diagnosis-A-Balloon-plot.jpg)
Relation of the tumor focality to mutation status and age of diagnosis.... | Download Scientific Diagram
![Overlap of biomarkers in patients with tumor marker data in FASTACT-2. | Download Scientific Diagram Overlap of biomarkers in patients with tumor marker data in FASTACT-2. | Download Scientific Diagram](https://www.researchgate.net/publication/301831495/figure/fig2/AS:613923740991498@1523382234115/Overlap-of-biomarkers-in-patients-with-tumor-marker-data-in-FASTACT-2.png)
Overlap of biomarkers in patients with tumor marker data in FASTACT-2. | Download Scientific Diagram
![Frontiers | Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis Frontiers | Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis](https://www.frontiersin.org/files/Articles/650491/fimmu-12-650491-HTML/image_m/fimmu-12-650491-g001.jpg)
Frontiers | Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
![Correlations between tumor burden as assessed by radiographic imaging... | Download Scientific Diagram Correlations between tumor burden as assessed by radiographic imaging... | Download Scientific Diagram](https://www.researchgate.net/publication/330448481/figure/fig3/AS:716056972779522@1547732694678/Correlations-between-tumor-burden-as-assessed-by-radiographic-imaging-CT-scans-or-CEA.png)